chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; Chills, severe headache, joint pain, muscle aches; This is a spontaneous report from a contactable consumer. A 48-year-old female patient received bnt162b2 (BNT162B2, lot number: EH9899), via an unspecified route of administration on the left arm on 17Dec2020 10:45 at a single dose for COVID-19 immunisation. Medical history included asthma and COVID-19 (patient was diagnosed with COVID-19 prior to vaccination). Concomitant medications included ascorbic acid, biotin, calcium carbonate, calcium pantothenate, calcium phosphate dibasic, chromium picolinate, colecalciferol, copper sulfate, cyanocobalamin, ferrous fumarate, folic acid, magnesium borate, magnesium oxide, manganese sulfate, nickel sulfate, nicotinamide, panax ginseng root, phytomenadione, potassium chloride, potassium iodide, pyridoxine hydrochloride, retinol acetate, riboflavin, sodium metavanadate, sodium molybdate, sodium selenate, stannous chloride, thiamine mononitrate, tocopheryl acetate, zinc oxide (CENTRUM ENERGY), and pantoprazole sodium sesquihydrate (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]). On 17Dec2020 13:00, the patient experienced chills, severe headache, joint pain, muscle aches. Therapeutic measure was not given as a result of the events. Clinical outcome of the events was not recovered.
This spontaneous report was received from a Nurse refers to a female patient of unknown age. On an unknown date in December 1970, the patient was vaccinated with MUMPSVAX (dose, route and frequency were not reported). The reporter stated that on an unknown date in 1992, the patient received the vaccination and it was not clear whether she received MMR II or whether she received a single antigen measles vaccine. The reporter stated the only available information about the 1992 administration was the lot number 0809T. On an unknown date, the patient experienced mumps. On an unknown date, the lab samples have been submitted to the CDC. The nurse reported that the labs submitted to the CDC were serum and buccal swabs. The lab results were pending to confirm mumps diagnosis. The patient sought medical attention. The patient was not taking any treatment. The outcome of the event was reported as recovering. The reporter did not provide the causality between the event and the suspect drug. Additional information has been requested.
Received Pfizer Covid Booster shot on 10-6-21. That evening had severe chills, fever, sweats, heart racing, headache, and wild hallucination/ dreams. A week later I am still experiencing wild dreams, neck and shoulder severe pain, fatigue, and inability to concentrate. Went to my primary care for general checkup to make sure I was OK and they said they are seeing many extended side effects.
My arm swelled up and was red about 2.5 inches. Swollen axillary LN left arm, and mildly sore inguinal LNs. I had severe headache, it was an unusual headache, muscle pains shooting through my body, feet hurt, nausea, extreme fatigue, diarrhea. This lasted for almost 3 days. The arm swelling last for 4 days. I am scared to get the booster.
Woke up 7am Sat 1/23/21 with muscle aches, headache, pain behind my eyes, fatigue, nausea and chest pain. Drank 1 liter of water and took 600mg of Advil. symptoms resolved at 8am until around 12pm. At 12pm symptoms returned and I took another 600mg of Advil. Symptoms did not resolve until around 2pm. At 3pm, symptoms had returned.  I took another 600mg of Advil around 5pm.  Symptoms did not resolve until around 7pm.  I went to sleep at 8pm
Developed tinnitus after my COVID vaccine administered on 04/01/2021. PFIZER EP6955 administered at clinic
Sore Arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore Arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027620A) for COVID-19 vaccination.     No Medical History information was reported.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore Arm). At the time of the report, PAIN IN EXTREMITY (Sore Arm) had resolved. Not Provided          Concomitant product use was not provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Reporter confirmed that reaction was not due to Moderna Vaccine; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
SARS-COV 2 PCR test positive; SARS-COV 2 PCR test positive; This is a literature report.  A 31-year-old female patient (unknown if pregnant) received COVID-19 Vaccine - Manufacturer Unknown, as dose 1, single (Lot number: unknown), as dose 2, single (Lot number: unknown) and as dose 3 (booster), single (Lot number: Unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant), outcome "recovered" and all described as "SARS-COV 2 PCR test positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive. Therapeutic measures were taken as a result of covid-19, drug ineffective.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Based on the information provided in the narrative, a causal association between the suspect drug and the events cannot be completely excluded.,Linked Report(s) : DE-PFIZER INC-202200740728 Same article, other patient (1)
I received the vaccination in the evening, and the following morning, had extreme pain in my injection site accompanied with swelling and redness.  I had a fever of 100.2, malaise, fatigue, and severe headache.  This lasted for over 48 hours, I was unable to get out of bed, had no appetite, and was extremely thirsty.  I took Motrin (400 mg) by mouth with no relief.  I then added Tylenol to the mix and was able to sleep some. I woke up this morning with burning sensation in my left arm at and around the injection site.  I applied a cold pack to the site for relief and took more Motrin. Today is day 5 and I still feel terrible.  No energy, bad headaches, and achy.
received shot monday. tuesday went to the park. started feeling ill. arm was hurting. pt went home and went to bed. was in bed most of the day. flu like symptoms achy no fever. wednesday  felt a little better but recently started feeling ill again. pt going home to go to bed again.
Pt stated he received a rash in the hip area at least 1 week after vaccination.  Pt stated the rash cleared on its own without seeking medical attention.
The day after the 2nd dose I had chills, head ache, felt nauseous. Second day these symptoms got worst and I threw up some with diarrhea. Today more head aches, lethargic, throwing up. I feel a little better this evening. Hoping to get back to work tomorrow. I felt it is important to report these side effects in the hope that there is on going research to make these vaccines less likely to cause bad side effects. This really knocked me down for the past few days.
Headache; Rapid heartbeat; Hives on face and neck; Rash on neck; Itchiness; Watery eyes; Extreme dryness on face; Sore arm at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the arm left on 27Mar2021 at 12:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm left on 05Mar2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Mar2021 at 15:30, the patient experienced headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events headache, rapid heartbeat, hives on face and neck, rash on neck, itchiness, watery eyes, extreme dryness on face and sore arm at injection site were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
7-8cm in diameter erythematous area rx deltoid-sl painful;APAP;
The symptoms I had were mild and lasted for a week. The only symptom I had that was concerning to me was that my blood pressure went really high. I was given steroid and when I checked with the doctor they said that and COVID-19 could make the blood pressure go high. So I only took them for 2 days and stopped when my BP went up. Then I started using MUCINEX. Other symptoms were sinus nasal and a cough. I feel fine now.
Narrative:  COVID infection following COVID vaccine series 06/02, Pfizer, dose #1 07/02, Pfizer, dose #2 07/07 COVID swab, result: NOT detected 07/13 CXR impression: 1. Mild left basilar atelectasis and slight elevation of the left hemidiaphragm. 07/19 ABG result: i-pH 7.43, i-PCO2 31.7, iPO2 73, i-HCO3 20.8 07/16 pt admitted to medicine cc: dizziness and gait dx: CVA LOS: 24 days 07/21 ABG result: i-pH 7.40, i-PCO2 31.9, iPO2 69, i-HCO3 19.8 07/21 amonia 37 07/25 CXR Impression: Interval extubation with slightly improved, increased lung volumes. 2. Patchy bibasilar parenchymal changes in the lungs. Findings could represent atelectasis or pneumonia. These are felt likely unchanged when allowing for the improved aeration on this exam. 08/03 PO4 results: 6.1 08/03 pt cc: loss of taste or smell, rhinorrhea, dyspnea, exposure: unknown 08/04 PT/INR 22.6/ 2.02 08/05 PT/INR 20.1/ 1.79 08/06 PT/INR 20.3/ 1.81 08/06 COVID swab, result: NOT detected 08/31 COVID swab, result: detected 10/16 pt deceased
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION( BREAKTHROUGH INFECTION); BRAIN FOG ASSOCIATED WITH BREAKTHROUGH INFECTION; COULDN'T DO NORMAL ACTIVITIES; FATIGUE; This spontaneous report received from a patient concerned a 68 year old Not Hispanic or Latino and white female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, expiry: 21-JUN-2021) dose was not reported,1 total administered on 07-APR-2021 to left arm for prophylactic vaccination (Dose number in series 1). No concomitant medications were reported. On 07-APR-2021, the patient experienced fatigue and couldn't do normal activities and on 15-NOV-2021 patient started not feeling well. On 19-NOV-2021, the patient experienced confirmed clinical vaccination failure and confirmed covid-19 infection (breakthrough infection). On NOV-2021, the patient experienced brain fog associated with breakthrough infection. Laboratory data included: SARS-CoV-2 PCR test (NR: not provided) Diagnosed with COVID-19. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fatigue on APR-2021, and couldn't do normal activities, had not recovered from brain fog associated with breakthrough infection, and the outcome of confirmed covid-19 infection( breakthrough infection) and confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report is associated with product quality complaint.  .; Sender's Comments: V0:20211229772-Covid-19 vaccine ad26.cov2.s- Confirmed clinical vaccination failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: SPECIAL SITUATIONS
Warm to touch; Heaviness, head feels heavy; Body aches; Pain in arm at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Warm to touch), HEAD DISCOMFORT (Heaviness, head feels heavy), MYALGIA (Body aches) and VACCINATION SITE PAIN (Pain in arm at the injection site) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FEELING HOT (Warm to touch), HEAD DISCOMFORT (Heaviness, head feels heavy), MYALGIA (Body aches) and VACCINATION SITE PAIN (Pain in arm at the injection site). At the time of the report, FEELING HOT (Warm to touch), HEAD DISCOMFORT (Heaviness, head feels heavy), MYALGIA (Body aches) and VACCINATION SITE PAIN (Pain in arm at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
This spontaneous report as received from a nurse practitioner refers to a 3 months old patient of unknown gender. No information on patient's medical history or concurrent conditions was provided. On 21-JAN-2015, the patient was vaccinated with the dose of PEDVAXHIB lot # K004541, expiration date: 04-DEC-2016 (dose, strength and route of administration were not reported), which had a temperature excursion (incorrect product storage). No information on patient's concomitant medication was provided. No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Child received hepatitis B shot and then returned to classroom. Teacher states that child fell face down on the floor after hitting her head on the desk. Teacher also observed shaking of the shoulders. Child did not respond to her when called upon. Nurses demonstrated child still lying on the floor with pulse. Breathing normal. Patient was lethargic.
Broke out in shingles/ small "half dollar size" spot of Shingles; itching; This case was reported by a consumer via call center representative and described the occurrence of shingles in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   In August 2021, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, 24 hrs after receiving Shingrix, the patient experienced shingles and pruritus. The patient was treated with hydrocortisone (Hydrocortisone Cream). On an unknown date, the outcome of the shingles and pruritus were recovered/resolved.   It was unknown if the reporter considered the shingles and pruritus to be related to Shingrix.  Additional details were provided as follows: The case was reported by the patient.   The patient received the first dose of Shingrix at the end of August.  Within about 24 to 30 hours of receiving the vaccine, the patient experienced itching and a small half dollar size spot of Shingles on her shoulder.  The patient applied hydrocortisone cream and it resolved over a weekend.   The patient was asking if she should get the second dose Lot number and expiration date for vaccine were unknown. The reporter did not consent to follow-up. There was discrepancy in the TTO and duration of event. TTO was captured as 24 hours as per follow up.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021221676:Same reporter - duplicate case
Had palpitations while I was sleeping that woke me up. Had numbness to right and left arms. Later that morning around 1130 had palpitations, dizziness,  lightheaded ness that would not go away even when sitting down. I felt numbness around my mouth took blood pressure and it was elevated 200 systolic and 100 systolic called EMS they assessed my blood pressure but it was normal systolic 130?s which is hi for me Norma blood pressure for me 90-100 systolic
Pt was admitted on 9/23 for a nontraumatic hemarthrosis of the left knee. She had a COVID test on 9/29 for discharge to rehab that was positive. Pt had COVID pneumonia with a nonproductive cough and required 2L nasal canula.
Approximately one week following injection, area around injection site is a hard, swollen red circle and feels itchy.
5/24/04: Mother called to report child's left upper arm had painful, swollen with redness at site after vaccinations. Mother states too, had small lump in left deltoid muscle. Mother stated swelling noticed since Saturday afternoon 05/20/2004.
I had Chills, low grade fever, site sorness, arm stiffness, worsened joint and muscle pain and fatigue for 3 days
Flu like Symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like Symptoms) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. U31620A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like Symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like Symptoms) outcome was unknown.            No concomitant medication reported  No treatment information was provided  COVID-19 Vaccination
Vaccinated while pregnant; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Vaccinated while pregnant) in a 38-year-old female patient (gravida 2, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 047A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (alcohol consumption reported to be 2-3 times per week) from 08-Jan-2000 to 30-Aug-2020 and Delivery (Patient had to undergo Intrauterine insemination (IUI) for first pregnancy.Pregnancy outcome: Live, full-term birth) on 06-May-2018. Concurrent medical conditions included Allergy to antibiotic (Allergic to levaquin), Fruit allergy (mango), Fruit allergy (papaya), Fruit allergy (guava) and Fruit allergy (passion fruit). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from an unknown date to 02-May-2021 for Pregnancy.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 09-Aug-2020 and the estimated date of delivery was 03-May-2021. On 16-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Vaccinated while pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-first week of the pregnancy. The vaginal delivery occurred on 01-May-2021, which was reported as Full-term. For neonate 1, the birth weight was 2721 grams (6lbs). The outcome was reported as Delivered NOS. Pregnancy outcome: Live, full-term birth. Patient delivered a baby boy at 40 weeks gestation period weighing 6 lbs and 19.5 inches in length. It was reported that no perinatal complications were observed for the infant, and that no fetal/infant abnormalities were identified on delivery and at 1-month post partum. On 16-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Vaccinated while pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Aug-2020, Pregnancy test: positive Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 15-APR-2021, the patient reported that she did not experience any side effects following both the vaccine doses while being pregnant, and that no treatment was required. On 21-JUN-2021, upon post-partum follow-up, it was reported that the patient did start to consume alcohol once a week as of 01-JUN-2021, and was reported to be breastfeeding.       Most recent FOLLOW-UP information incorporated above includes: On 21-Jun-2021: Significant follow-up received :- updated pregnancy outcome details
syncopal episode; on the way home from MD office pt fell forward (in seat belt) & became unresponsive for a short time; mom stopped @ friends & called MD office; advised to return-pt checked by MD;
neuropathy on her left hand and foot, it never got better/got worse in her left arm and hand; had a knot came up under her arm; This is a spontaneous report from a contactable consumer. A 52-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), first dose on an unspecified date (batch/lot number and expiration date were not reported) and second dose on an unspecified date (batch/lot number and expiration date were not reported); both via an unspecified route of administration, administered in the left arm as a single dose for COVID-19 immunization. Relevant medical history indicated that the patient had suffered with neuropathy for years and her vitamin D levels were low; both from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. After the first dose on an unspecified date, the patient had a knot came up under her arm within the first 24 hours and neuropathy on her left hand and foot; it never got better. She received the second dose and it got worse in her left arm and hand. She also got another knot under her left arm. The events took place after use of the product. The patient was not recovered from the events.  Information on the batch/lot number has been requested.
Patient developed diffuse myoclonic activity 2-5 days after vaccine with subsequent full resolution.